Sharekhan's research report on Zydus Wellness
In Q1FY2020, Zydus Wellness’ comparable revenue grew by ~10% (Heinz portfolio grew 20% on a comparable basis). OPM expanded strongly to 19.7% in Q1FY2020 as against 8.1% in Q1FY2019, led by lower advertisement spends and operating efficiencies. We have increased our earnings estimates factoring in higher-than-estimated growth for the Heinz portfolio.
Outlook
We upgrade Zydus to Buy with a revised price target (PT) of Rs. 1,780 on strong show by the Heinz portfolio.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!